DeFi trial: Smart design and impressive results for the benefit of patients with rare cancers

Retrieved on: 2022-09-11 02:02:31

Tags for this article:

Health

European Organisation for Research and Treatment of Cancer

European Society for Medical Oncology

Aggressive fibromatosis

Grant

European Cancer Organisation

AstraZeneca

Clinical trial

Click the tags to see associated articles and topics

DeFi trial: Smart design and impressive results for the benefit of patients with rare cancers. View article details on HISWAI: https://www.eurekalert.org/news-releases/963814

Excerpt

Credit: European Society for Medical Oncology ... Rome/Italy, 17Division Of Hematology/medical Oncology, Oregon Health & Science University, ...

Article found on: www.eurekalert.org

View Original Article